Diabetes Technology and Therapeutics
Journal Impact IF - Analysis · Trend · Prediction · Ranking


New

Journal Impact IF

2019-2020

4.403

-1.9 %

Journal Impact IF Trend

Diabetes Technology and Therapeutics

The 2019-2020 Journal Impact IF of Diabetes Technology and Therapeutics is 4.403, which is just updated in 2020.

Highest IF
4.488
Highest Journal Impact IF

The highest Journal Impact IF of Diabetes Technology and Therapeutics is 4.488.

Lowest IF
1.931
Lowest Journal Impact IF

The lowest Journal Impact IF of Diabetes Technology and Therapeutics is 1.931.

Total Growth Rate
128.0%
IF Total Growth Rate

The total growth rate of Diabetes Technology and Therapeutics IF is 128.0%.

Annual Growth Rate
14.2%
IF Annual Growth Rate

The annual growth rate of Diabetes Technology and Therapeutics IF is 14.2%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Medical Laboratory Technology Q1 2/28

Medical Laboratory Technology 94%

Endocrinology, Diabetes and Metabolism Q1 26/217

Endocrinology, Diabetes and Metabolism 88%

Endocrinology Q1 17/118

Endocrinology 86%

Journal Impact IF Ranking

· In the Medical Laboratory Technology research field, the Quartile of Diabetes Technology and Therapeutics is Q1. Diabetes Technology and Therapeutics has been ranked #2 over 28 related journals in the Medical Laboratory Technology research category. The ranking percentile of Diabetes Technology and Therapeutics is around 94% in the field of Medical Laboratory Technology.
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Diabetes Technology and Therapeutics is Q1. Diabetes Technology and Therapeutics has been ranked #26 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Diabetes Technology and Therapeutics is around 88% in the field of Endocrinology, Diabetes and Metabolism.
· In the Endocrinology research field, the Quartile of Diabetes Technology and Therapeutics is Q1. Diabetes Technology and Therapeutics has been ranked #17 over 118 related journals in the Endocrinology research category. The ranking percentile of Diabetes Technology and Therapeutics is around 86% in the field of Endocrinology.

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 4.403
2018-2019 4.488
2017-2018 2.921
2016-2017 2.698
2015-2016 2.198
2014-2015 2.106
2013-2014 2.293
2012-2013 2.205
2011-2012 1.931
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Diabetes Technology and Therapeutics is 4.403
· The 2018-2019 Journal Impact IF of Diabetes Technology and Therapeutics is 4.488
· The 2017-2018 Journal Impact IF of Diabetes Technology and Therapeutics is 2.921
· The 2016-2017 Journal Impact IF of Diabetes Technology and Therapeutics is 2.698
· The 2015-2016 Journal Impact IF of Diabetes Technology and Therapeutics is 2.198
· The 2014-2015 Journal Impact IF of Diabetes Technology and Therapeutics is 2.106
· The 2013-2014 Journal Impact IF of Diabetes Technology and Therapeutics is 2.293
· The 2012-2013 Journal Impact IF of Diabetes Technology and Therapeutics is 2.205
· The 2011-2012 Journal Impact IF of Diabetes Technology and Therapeutics is 1.931

Diabetes Technology and Therapeutics
Journal Profile
Diabetes Technology and Therapeutics | Academic Accelerator - About the Journal

About

Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.

ISSN
1520-9156
ISSN

The ISSN of Diabetes Technology and Therapeutics is 1520-9156 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
1557-8593
ISSN (Online)

The ISSN (Online) of Diabetes Technology and Therapeutics is 1557-8593 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
Mary Ann Liebert Inc.
Publisher

Diabetes Technology and Therapeutics is published by Mary Ann Liebert Inc. .

Publication Frequency
Bimonthly
Publication Frequency

Diabetes Technology and Therapeutics publishes reports Bimonthly .

Coverage
1999 - Present
Coverage

The Publication History of Diabetes Technology and Therapeutics covers 1999 - Present .

Open Access
NO
Open Access

Diabetes Technology and Therapeutics is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Review
Publication Fee

There is no publication fee for submiting manuscript to Diabetes Technology and Therapeutics. Diabetes Technology and Therapeutics is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

Language
English
Language

The language of Diabetes Technology and Therapeutics is English .

Country/Region
United States
Country/Region

The publisher of Diabetes Technology and Therapeutics is Mary Ann Liebert Inc. , which locates in United States .

Popular Journals

What is Impact Factor?

The impact factor (IF) is frequently used as an indicator of the importance of a journal to its field. It was first introduced by Eugene Garfield, the founder of the Institute for Scientific Information. Although IF is widely used by institutions and clinicians, people have widespread misconception regarding the method for calculating the journal IF, its significance and how it can be utilized. The IF of a journal is not associated to the factors like quality of peer review process and quality of content of the journal, but is a measure that reflects the average number of citations to articles published in journals, books, thesis, project reports, newspapers, conference/seminar proceedings, documents published in internet, notes, and any other approved documents.

Diabetes Technology and Therapeutics | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The Diabetes Technology and Therapeutics Journal Impact IF measures the average number of citations received in a particular year (2020) by papers published in the Diabetes Technology and Therapeutics during the two preceding years (2018-2019). Note that 2020 Journal Impact are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of Diabetes Technology and Therapeutics.